Rollins Inc
NYSE:ROL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
39.97
51.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Rollins Inc
Accrued Liabilities
Rollins Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Rollins Inc
NYSE:ROL
|
Accrued Liabilities
$272.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
||
Waste Management Inc
NYSE:WM
|
Accrued Liabilities
$1.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
||
Clean Harbors Inc
NYSE:CLH
|
Accrued Liabilities
$468.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
||
Republic Services Inc
NYSE:RSG
|
Accrued Liabilities
$1.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
||
Tetra Tech Inc
NASDAQ:TTEK
|
Accrued Liabilities
$395.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
||
Veralto Corp
NYSE:VLTO
|
Accrued Liabilities
$217m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Rollins Inc
Glance View
Rollins Inc. is a prominent player in the pest control industry, renowned for its commitment to providing effective and environmentally responsible solutions to its diverse client base. Founded in 1964, the company has steadily grown through a robust network of franchises and acquisitions, offering services that cover residential, commercial, and industrial sectors. Rollins operates under several well-known brands, including Orkin, pest control giant, and others, positioning itself as a trusted name in managing pest-related concerns. The company's focus on customer service, cutting-edge technology, and sustainable practices has fostered long-term relationships with clients, ultimately enhancing its market share and driving consistent revenue growth. Investors looking at Rollins Inc. will find a company that not only demonstrates resilience in a stable industry but also showcases a strong balance sheet supported by a track record of profitability and cash flow generation. The pest control market is expected to expand further, fueled by increasing demand for pest management solutions and heightened awareness of public health issues. Rollins has strategically positioned itself to capitalize on this trend, with ongoing investments in employee training and technology to optimize operations and improve customer satisfaction. With a history of prudent capital allocation and a commitment to maintaining its leadership in the industry, Rollins Inc. presents an attractive opportunity for investors seeking stability and growth potential in a traditionally recession-resistant sector.
See Also
What is Rollins Inc's Accrued Liabilities?
Accrued Liabilities
272.1m
USD
Based on the financial report for Sep 30, 2024, Rollins Inc's Accrued Liabilities amounts to 272.1m USD.
What is Rollins Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
11%
Over the last year, the Accrued Liabilities growth was 16%. The average annual Accrued Liabilities growth rates for Rollins Inc have been 9% over the past three years , 10% over the past five years , and 11% over the past ten years .